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Abstract
Background: Enterocystoplasty is associated with serious complications resulting
from the chronic interaction between intestinal epithelium and urine. Composite
cystoplasty is proposed as ameans of overcoming these complications by substituting
intestinal epithelium with tissue-engineered autologous urothelium.
Objective: To develop a robust surgical procedure for composite cystoplasty and to
determine if outcome is improved by transplantation of a differentiated urothelium.
Design, setting, and participants: Bladder augmentation with in vitro–generated
autologous tissues was performed in 11 female Large-White hybrid pigs in a well-
equipped biomedical centre with operating facilities. Participants were a team
comprising scientists, urologists, a veterinary surgeon, and a histopathologist.
Measurements: Urothelium harvested by open biopsy was expanded in culture and
used to develop sheets of nondifferentiated or differentiated urothelium. The sheets
were transplanted onto a vascularised, de-epithelialised, seromuscular colonic segment
at the time of bladder augmentation. After removal of catheters and balloon at
two weeks, voiding behaviour was monitored and animals were sacriﬁced at 3 months
for immunohistology.
Results and limitations: Eleven pigs underwent augmentation, but four were lost to
complications. Voiding behaviour was normal in the remainder. At autopsy, recon-
structed bladders were healthy, lined by conﬂuent urothelium, and showed no
ﬁbrosis, mucus, calculi, or colonic regrowth. Urothelial morphology was transitional
with variable columnar attributes consistent between native and augmented seg-
ments. Bladders reconstructed with differentiated cell sheets had fewer lymphocytes
inﬁltrating the lamina propria, indicating more effective urinary barrier function.
Conclusions: The study endorses the potential for composite cystoplasty by (1) suc-
cessfully developing reliable techniques for transplanting urothelium onto a prepared,
vascularised, smooth muscle segment and (2) creating a functional urothelium-lined
augmentation to overcome the complications of conventional enterocystoplasty.
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Although the management of severe bladder dysfunction
has been transformed by enterocystoplasty, the use of
intestine to increase capacity and compliance is associated
with relatively common and potentially serious complica-
tions attributable to prolonged interaction of urine and the
mucus-producing, absorptive, intestinal epithelium [1].
Alternatives to conventional enterocystoplasty, such as
ureterocystoplasty, have proven to be of very limited
application. In light of current knowledge, the only reliable
means to create a urothelium-lined neobladder of ade-
quate functional capacity is likely to entail the use of tissue
engineering.
We have previously reported the development of
reliable cell-culture systems for generating clinically
relevant areas of normal human urothelium in vitro [2].
In addition, we have described the concept of composite
enterocystoplasty, in which autologous urothelium prop-
agated in vitro is combined with a segment of de-
epithelialised bowel at the time of surgical reconstruction
[3]. This offers significant advantage over other tissue-
engineering strategies as it exploits the patient’s vascu-
larised smooth-muscle tissue and requires onlyurothelium
to be engineered in vitro.
The concept of composite cystoplasty was successfully
piloted in a surgical minipig model using autologous
cultured urothelium combined with vascularised uterine
smooth muscle [3]. While proof of principle was demon-
strated, histologic analysis indicated incomplete urothe-
lial coverage and some regrowth by residual foci of uterine
epithelium. Moreover, inflammatory changes were con-
sidered attributable to inadequate integrity of the
urothelial barrier, resulting in exposure of the stroma to
urine. This study was designed to address these problems
by:
 Promoting rapid functional integrity of the cystoplasty
by using differentiated, rather than proliferative,
urothelium. To this end, we have already demonstrated
the potential of cultured, normal, human and porcine
urothelial cells to form stratified, differentiated urothe-
lia with barrier properties as assessed by high,
transepithelial electrical resistance and low permeabil-
ity [4,5].
 Confirming the feasibility of composite cystoplasty using
de-epithelialised colonic segments. Technical difficulty
in de-epithelialising the thin-walled porcine colon
necessitated the use of uterine smooth muscle in our
earlier study [3]. But, since it is envisaged that colon
would be used for composite cystoplasty in humans, we
modified and applied a technique of extraluminal
dissection [6].
 Confirming whether urothelium lining the augmenting
segments originates from cultured cells implanted at the
time of reconstruction or ingrowth from surrounding
native tissues. To this end, a reporter gene was integrated
into cultured porcine urothelial cells for subsequent
immunodetection.2. Materials and methods
2.1. Animal procedures
Large-White hybrid (LWH) (Sus scrofa) female pigs weighed 25–30 kg.
All procedures were undertaken in compliance with statutory regula-
tions using standard protocols. Preliminary studies were performed
using fresh bladder and colon from LWH pigs from an abattoir.
2.2. Harvest of urothelium
The bladder was delivered through a lower, midline, abdominal incision,
opened in the midline, and a 1–2-cm2 area of full-thickness tissue
harvested and transferred into transport medium [2] with 1 mg/ml
amphotericin B, 100 U/ml penicillin, and 100 mg/ml streptomycin. The
bladder and abdomen were closed with absorbable sutures.
2.3. Normal porcine urothelial cell culture
Normal porcine urothelial (NPU) cells were isolated and propagated as
described [3]. Brieﬂy, bladder tissue was incubated in 0.5% (weight per
volume) dispase II (Roche Diagnostics Ltd, West Sussex, UK) to separate
the urothelium, which was collected, treated with collagenase, and
seeded into Primaria culture ﬂasks (BD Falcon, Becton, Dickinson UK,
Oxford, Oxfordshire, UK) at 4  104 cells per square centimetre in
antibiotic-free, keratinocyte serum-free medium (KSFM) containing
recombinant epidermal growth factor and bovine pituitary extract
(Invitrogen Ltd, Paisley, UK) and 30 ng/ml cholera toxin (Sigma-Aldrich,
St. Louis, USA) as KSFM complete (KSFMc) [2]. Cultures were maintained
at 37 8C and subcultured at just conﬂuence [2].
2.3.1. Stable integration of enhanced green fluorescent protein
(eGFP) into porcine urothelial cells
The plasma eGFP-C1 (pLeGFP-C1) retroviral vector was transfected into
PT67 packaging cells as recommended (Clontech, Mountain View, CA,
USA). Replication-deﬁcient virions were collected and used to transduce
NPU cells, which were selected and maintained in KSFMc containing
0.1 mg/ml G418 sulphate. Assessment of eGFP expression was
performed by direct epiﬂuorescent microscopy or, following formation
and harvest of urothelial cell sheets (see below), formalin-ﬁxed, parafﬁn
wax-embedded sections were immunoperoxidase labelled using a
monoclonal antibody against GFP (Table 1 and Section 2.3.4).
2.3.2. Differentiation and cell sheet formation
NPU cells were switched from proliferative to differentiated phenotype
as described [5]. NPU cell cultures were subcultured in medium
containing 5% bovine serum; cell sheets were formed 16 h prior to
surgery by adjusting the calcium concentration to 2.5 mMbefore harvest
using dispase [3]. In preliminary experiments, the viability of urothelial
cell sheets was tested by transfer onto a de-epithelialised stroma and
maintenance in organotypic culture [7].
For surgical transplantation, a trimmed Vicryl mesh from a renal
prosthesis bag (VM102, Ethicon, Berkshire, UK) was placed onto the
surface of the detaching cell sheet to facilitate transfer to the de-
epithelialised bowel while maintaining correct urothelial polarity
(Fig. 1).
2.3.3. Composite cystoplasty
The technique of extramucosal colonic dissection was used to develop a
vascularised, de-epithelialised, seromuscular segment of mean size
17.5 cm2 (range: 15–21 cm2). A Foley catheter was inserted rectally and
the balloon ﬁlled with sterile water within the portion of sigmoid bowel
to be dissected (Fig. 2a). The dissection limits of the bowel and
[()TD$FIG]
Fig. 1 – Maintenance of urothelial polarity by association with Vicryl mesh
to form the delivery vehicle for transplant onto the seromuscular
segment during composite cystoplasty. The Vicryl covers the luminal
aspect of the reconstruction, acting as a protective layer apposed to the
intravesical balloon and providing a substrate for suture.
[()TD$FIG]
Fig. 2 – The different stages of composite cystoplasty. (a) To develop a
vascularised, de-epithelialised seromuscular segement, a Foley catheter
was inserted rectally and the balloon filled with sterile water within the
portion of sigmoid bowel to be dissected. The dissection limits of the
bowel and mesentery were defined; (b) Using the balloon as a support,
the seromuscular layer of the bowel was incised and separated from the
lamina propria deep to the mucosa; (c) The vascularised, deepithelialised
patch was isolated and received the autologous tissue engineered
urothelial cell sheet in complex with the Vicryl mesh. The mesenteric
fenestration was closed to prevent internal hernia; (d) The bladder was
opened widely and augmented with the composite bowel segment.
Gentle distension of the augmented bladder was maintained with a
silicone vesical conformer. Urine was diverted postoperatively with
ureteric stents and a Malecot suprapubic catheter. Stages (c) and (d),
respectively, are illustrated in (e) and (f) during an actual composite
cystoplasty operation. (e1) Patches of Vicryl mesh supporting urothelial
cell sheets against de-epithelialised colon; (e2)vesical conformer
(collapsed); (e3) opened native bladder; (e4) Malecot suprapubic
catheter; (e5) filling tube for vesical conformer; (e6) detubularised colon;
(e7) ureteric catheters.
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the balloon as a support, the seromuscular layer of the bowel was incised
and separated from the lamina propria deep to the mucosa (Fig. 2b). The
vascularised, de-epithelialised patch was isolated and received the
autologous tissue-engineered urothelial sheet in complex with
the Vicryl mesh, which was secured in place using 8/0 Vicryl sutures
and maintaining the normal polarity of the urothelium (Fig. 2c). The
seromuscular edges from the remaining bowel were apposed and
sutured, ‘‘intussuscepting’’ the devascularised mucosa. The mesenteric
fenestration was also closed to prevent internal hernia. The bladder was
opened widely and augmented with the composite bowel segment
(Fig. 2d). Gentle distension of the augmented bladder was maintained
with a silicone vesical conformer (Silimed, Rio de Janeiro, Brazil), which
served to gently appose the graft to the de-epithelialised stroma. Urine
was diverted postoperatively with ureteric stents (Vygon 4FG feeding
tubes; Vygon, Ecouen, France) and a Malecot suprapubic catheter
(Rusch; Teleﬂex, Limerick, PA, USA). The abdomenwas closed; catheters,
drains, and tubing were secured externally with sutures.
Catheters and the deﬂated conformer were removed under sedation
after 2 wk. Postsacriﬁce at 3 mo, bladders were collected and processed
for immunohistology.
2.3.4. Immunohistology
Native and augmented bladder segments were trimmed and ﬁxed in 10%
formalin for 24 h. Tissue was dehydrated through ethanol into xylene
and embedded in parafﬁn wax. Dewaxed ﬁve micrometre sections were
either stained with haematoxylin and eosin to deﬁne the overall
structure of the augmented neobladders or labelled with antibodies
against speciﬁc markers. CK7, CK13, and CK18 were used to deﬁne theTable 1 – Antibodies used for determination of tissue phenotype
Antigen Antibody Source
CK7 OV TL 12/30 Novocastra
CK13 CK13.1 ICN
CK14 LL002 Serotec
CK18 CY90 Sigma
CD3 SP7 Abcam
UP3Ka AU1 Progen
Ki-67 MM1 Novocastra
Anti-GFP – Roche
* Antigens masked by tissue processing were retrieved either by boiling in citric
recommended by the antibody manufacturer.phenotype of the tissue in relation to the epithelial lining. UPK3a was
included as a marker of urothelial differentiation. The normality of the
tissues was further appraised by mitotic index, inﬂammation, and
squamous metaplasia assessed using Ki-67, CD3, and CK14, respectively.Dilution Antigen retrieval method*
1 in 400 A
1 in 10 A
1 in 500 B
1 in 5000 A
Undiluted A
1 in 40 A
1 in 100 A
1 in 400 A
acid buffer (method A) or combined with trypsinisation (method B), as
[()TD$FIG]
Fig. 3 – (a) Haematoxylin and eosin–stained section of stratified
urothelium that showed (b) apical expression of the terminal
differentiation marker, UPK3a. Scale bar: 50 mm.
[()TD$FIG]
Fig. 4 – Retroviral transduction of pig urothelial cell cultures with
enhanced green fluorescent protein (eGFP) as a marker protein.
(a) Expression of eGFP demonstrated by epifluorescent microscopy.
Nuclei are stained with Hoechst 33258 (blue). Scale bar: 10 mm.
(b) Immunohistology with anti-GFP monoclonal antibody on
differentiated, pig urothelial cell sheets developed from transduced pig
urothelial cell culture and (c) nontransduced, pig urothelial, control cell
culture to show specificity of eGFP labelling. Scale bars: 50 mm.
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and binding of primary antibodies was detected using an indirect
streptavidin avidin-biotin immunoperoxidase technique. Antigens
masked by tissue processing were retrieved either by boiling in citric
acid buffer or by combining with trypsinisation (Table 1).
3. Results
3.1. Validation of cell-culture techniques
The capacity for in vitro-generated, differentiated urothelial
sheets to attach and survive on a de-epithelialised stroma
was confirmed by organ culture (Fig. 3).
NPU cultures were transduced with GFP retrovirus with
100% efficiency. Transduced cultures were fluorescent
(Fig. 4a) and there was no attenuation of eGFP expression
over serial passage, despite withdrawal of antibiotic
selection. Transduced cells appeared morphologically
normal with no reduction in culture lifespan. eGFP could
also be detected immunohistochemically on paraffin wax-
processed sections of in vitro–differentiated transduced
NPU sheets (Fig. 4b).
3.2. Extraluminal seromuscular dissection of the colon
Extraluminal dissection of the seromuscular plane was
piloted in cadaveric pigs and confirmed clean separation of
mucosa from the underlying musculature of the seromus-
cular segment. Histologically, the de-epithelialised segment
appeared well-vascularised with no evidence of residual
crypts. The mucosa showed complete separation from the
underlying musculature with no ingress into the crypts.3.3. Composite cystoplasty
3.3.1. Stage 1: Bladder tissue harvest for cultivation
Bladder specimens of 1.5–2 cm2 were harvested from
15 animals. Successful NPU cultures were established from
13 animals, with the number of cells recovered at biopsy
ranging from 0.86  106 to 7.06  106. These were sub-
cultured between three and eight times to achieve clinically
useful quantities ranging between 17.3  106 and
123.40  106 cells (mean: 55.4  106 cells), with 10% of
cells cryopreserved following the first passage. One animal
was euthanised because of a large incisional hernia and
another succumbed to anaesthetic complications, leaving
11 animals for reconstruction.
3.3.2. Stage 2: Bladder augmentation
Bladder augmentation was performed a minimum of 4 wk
after harvest of tissue for NPU culture. No technical
[()TD$FIG]
Table 2 – Comparison of size of graft at the time of composite cystoplasty and after 3 mo
Pig Surface area of graft. cm2 Change in size, %
At composite cystoplasty Postmortem after ﬁxation with formalin*
1 16 6 62.5
2 16.25 15 7.7
3 16.25 18 +10.8
4 18.75 22.5 +20
5 21 19.25 8.3
6 15 22.75 +51.7
7 21 24.5 +16.7
* Nonabsorbable sutures (prolene) were placed at each corner of the posteriorly applied graft to allow accurate measurement of graft size in the last four animals.
In the first three animals, margins were approximated from the macroscopic appearance of the graft.
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died from an adverse reaction to sedation during catheter
removal. Early in the study, three pigs died postoperatively
due to sepsis secondary to urine extravasation (around a
catheter in one animal and from the suture line in two
animals). Thereafter precautions were taken to safeguard
vascularity at themargins of the seromuscular segment and
prevent leakage from the bladder at the exit site of the
suprapubic catheter. Seven animalsmade an uncomplicated
recovery and survivedwithout complication to sacrifice at 3
mo. Normal voiding was observed to be rapidly reestab-
lished following catheter removal and was maintained to
sacrifice without complication.
3.3.3. Stage 3: Analysis of reconstructed bladders
3.3.3.1. Macroscopic appearance. At autopsy, all seven recon-
structed bladders appeared healthy and well healed with no
ulcers, mucus, calculi, or any other focal lesion within the
lumen.Noneof the composite segmentswere contracted and
the vascular pedicles were normal. The Vicryl mesh had
completely degraded in all animals. After fixation, the graft
surface area was calculated and compared with measure-
ments obtained at the time of composite cystoplasty
(Table 2). Although some augments were reduced in size,
no morphologic evidence of fibrosis was found. Shrinkage of
visceral tissue is known to occur not only upon fixation in
formalin but also immediately after evisceration in air [15].
All bowel anastomoses were well healed and the luminal
[()TD$FIG]Fig. 6 – Immunohistochemistry of native and augmented bladder
segments constructed using either nondifferentiated or differentiated
urothelial cell sheets. Urothelium from all reconstructed bladders
expressed CK13 and UPK3a, and only bladders reconstructed with
nondifferentiated urothelium showed any evidence of expression of
CK14. Scale bar: 50 mm.
Fig. 5 – Low-power histology of augmented bladder across the
anastomosis between native and augmented segments. Note
the junction between colonic and detrusor smooth muscle and the
uninterrupted coverage by urothelium. Scale bar: 1 mm.surfaceat the resectionsiteappearednormalwithnoresidual
intussuscepted tissue.
3.3.3.2. Histology. A clear demarcation was present between
bladder and bowel smoothmuscle at the site of anastamosis
(Fig. 5).
Augmented segments were completely covered with
confluent urothelium. Whereas some samples appeared
Table 3 – Morphologic and phenotypic properties of reconstructed bladders
Pig Augmenting urothelium Passages, No. Morphology of augmented segment Phenotype
1 Differentiated 8 Transitional with columnar attributes Transitional; UPIIIa positive
2 Proliferative 5 Transitional Transitional; UPIIIa positive
3 Differentiated 5 Transitional Transitional; UPIIIa positive
4 Differentiated 7 Transitional with columnar attributes Transitional; UPIIIa positive
5 Proliferative 3 Transitional with columnar attributes Transitional; UPIIIa positive
6 Proliferative 4 Transitional Transitional; UPIIIa positive
7 Differentiated plus eGFP 5 Transitional with columnar attributes Transitional; UPIIIa negative; eGFP negative
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some columnar attributes, such as tall, aligned cells with
basally located nuclei (Fig. 6, Table 3). The histology was
identical in augmented and adjacent native bladder at the
time of sacrifice with no differences relating to the use of
nondifferentiated or differentiated urothelium at the time
of augmentation. No evidence of colonic-crypt regrowth
was seen in any of the augmented bladders. Inflammation
was minimal, although the density of lymphocytic infiltrate
in the lamina propria in bladders reconstructed with
nondifferentiated urothelium was greater than with differ-
entiated urothelium.
3.3.3.3. Immunohistochemistry. Expression of CK7, CK13 and
CK18 was detected in native urothelium, but not colonic
tissues (Fig. 7). These same isotypes were detected in the
epithelium overlying the augmented segments, with the
exception of CK7 in one augment constructed with
nondifferentiated urothelium and CK18 in two augments[()TD$FIG]
Fig. 7 – Immunohistochemistry of native pig bladder and colon. The
normal expression of CK13, CK14, and UPK3a is shown for comparison
with Figure 6. Note expression of CK13 and UPK3a provides markers that
differentiate urothelial from colonocyte differentiation, whereas CK14 is
not normally expressed by either tissue. Scale bar: 50 mm.constructed with differentiated urothelia. CK14was neither
expressed in native porcine urothelia nor colonic epithelia,
but was expressed basally and most abundantly in the
native and augmented segments of bladders constructed
with nondifferentiated urothelia. UPK3a was expressed
along the superficial edge of native urothelium in all
augmented segments, with the exception of the bladder
constructed with differentiated eGFP-expressing urothe-
lium. Cell-cycle activity, assessed by Ki67 expression, was
similar in augmented and adjacent native urothelium.
In the pig constructed with differentiated eGFP-tagged
cells, no eGFP immunolabelling could be detected in the
augmented (or native) segment of the bladder, although the
corresponding NPU cells had expressed GFP prior to
transplantation. Notably, this was the only sample that
did not express UPK3a. In all other respects, the bladder
constructed with eGFP-transduced cells was similar to the
other reconstructed bladders.
4. Discussion
We have demonstrated successful implementation of
composite cystoplasty for bladder reconstruction in a
porcine model. Normal voiding was reestablished soon
after surgery and examination of the reconstructed bladders
after 3 mo demonstrated viable, vascularised, composite
cystoplasty segments with no fibrosis or contraction.
Augmented segments were completely lined by confluent
urotheliumwithminimal inflammatory changes, indicating
effective barrier function. In humans, UPK3a provides an
objective marker of late/terminal urothelial differentiation
whose expression parallels the development of a functional
barrier; this relationship is more tenuous in pig urothelium,
however, where UPK3a is expressed by stratified cultures
that have not developed barrier properties [5]. This high-
lights that while the pig is a valuable model for developing
and testing surgical procedures, it is not a direct substitute
for human studies. In culture, NPU cells were more
fastidious than normal human urothelial (NHU) cells and,
despite optimising procedures for growing, differentiating,
and transferring sheets of porcine urothelium, cell-culture
results were inferior to equivalent results using NHU cells.
We postulated that implanting sheets of differentiated
urothelium would establish more rapid, effective barrier
function and noted reduced urothelial CK14 expression and
fewer lymphocytes in the subaugment stroma of bladders
reconstructed with differentiated urothelium. These find-
ings support reconstruction with differentiated, rather than
proliferative, urothelium.
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tered previously in dissecting the thin-walled porcine colon
[3]. By employing a modified technique of extraluminal
dissection [6], it was possible to create well-vascularised
seromuscular segments that retained viability when
combined with autologous urothelium. At the time of
sacrifice there was no evidence of contraction of the
augmenting segments and histology revealed healthy
smooth muscle with no evidence of fibrosis. Importantly,
a clean plane of separation was achieved at the level of the
lamina propria, thus preventing any colonic mucosal-cell
regeneration from the basal crypt compartment. Compared
to the pig, human sigmoid colon has a thickmuscle wall and
the feasibility of demucosalisation by open dissection is
established [8,9]. Nevertheless, the use of extramucosal
dissection has the benefit of reducing risk of sepsis by
preventing peritoneal soiling with intestinal content.
Composite cystoplasty has the advantage of retaining the
compliant properties imparted by the native smooth
muscle of the bowel wall while limiting the requirement
for tissue engineering to a single, autologous cell type
(urothelium). This is a much less challenging approach than
that taken by others in attempting to create a fully tissue-
engineered bladder wall [10]. Whereas the properties of
cultured urothelium are well documented, the biologic and
functional properties of cultured smooth-muscle cells are
far less well understood. Experience with composite
cystoplasty is limited to a porcine experimental model
that awaits objective assessment of functional outcome.
However, our findings indicate that an approach which
combines tissue-engineered urothelium with host smooth
muscle may provide a more robust approach than one
dependent upon the uncertain functionality of tissue-
engineered smooth muscle.
Reported observations in experimental animals and in
patients with neobladder augments derived from cultured
urothelial and detrusor cells have indicated an advantage
from regular postoperative distension (‘‘bladder cycling’’) to
facilitate the development of adequate bladder capacity and
compliance [11]. We found some evidence of a glandular
type of reaction in both augmented and native segments of
some reconstructed bladders. This was unrelated to the use
of proliferative or differentiated urothelium and is likely to
reflect an individual, nonspecific response to the presence
of the catheters and balloon [12].
We have shown in organ culture that urothelial sheets
form integrated basement membrane attachments to the
stroma within 24 h of transplant [13], suggesting that
future refinement of composite cystoplasty might include
earlier removal of balloons and catheters to limit any
metaplastic response to the materials.
Although it was an original aim of our study, we
were unable to demonstrate unequivocally whether the
urothelium of the augmented segment derived from
the transplanted sheet or from ingrowth of the native
urothelium. The former is most likely as the outcome
reflected the type of urothelium transplanted and previous
control reconstructions performed with de-epithelialised
stroma did not demonstrate urothelial overgrowth [3].However, the inability to demonstrate GFP expression in
vivomeant that wewere unable to address this categorically
and a small possibility must remain that the transplanted
urothelium provided a ‘‘feeder’’ effect that promoted
ingrowth of native urothelium.
Finally, it is important to acknowledge that in common
with virtually all experimental bladder-tissue engineering
studies, this work was undertaken using animals with
normal bladders. Before this technique is translated into
clinical practice it will be important to evaluate the growth
and differentiation capacity of urothelial cells harvested
from diseased human bladders.
5. Conclusions
We have described successful application of composite
enterocystoplasty in a porcine model, comprising an aug-
menting smooth-muscle segment linedby invitro–generated
autologous urothelium. None of the well-documented
complications of conventional enterocystoplasty were en-
countered in the augmented bladders.
We suggest the approach is close to translation to human
subjects once reliance on bovine factors is removed and a
more efficient method to harvest urothelial cell sheets is
identified, with thermoresponsive polymer technology
providing one option [14].
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